Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Vasomotor Symptoms of Menopause Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Vasomotor Symptoms of Menopause Treatment Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Estetrol
    • 1.4.3 Fezolinetant
    • 1.4.4 FP-101
    • 1.4.5 HBN-2
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Homecare
    • 1.5.4 Clinic
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Vasomotor Symptoms of Menopause Treatment Market Perspective (2015-2026)
  • 2.2 Global Vasomotor Symptoms of Menopause Treatment Growth Trends by Regions
    • 2.2.1 Vasomotor Symptoms of Menopause Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Vasomotor Symptoms of Menopause Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Vasomotor Symptoms of Menopause Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Vasomotor Symptoms of Menopause Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Market Size
    • 3.1.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Vasomotor Symptoms of Menopause Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio
    • 3.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Vasomotor Symptoms of Menopause Treatment Revenue in 2019
  • 3.3 Vasomotor Symptoms of Menopause Treatment Key Players Head office and Area Served
  • 3.4 Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
  • 3.5 Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)
  • 5.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
  • 6.2 Vasomotor Symptoms of Menopause Treatment Key Players in North America (2019-2020)
  • 6.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
  • 6.4 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
  • 7.2 Vasomotor Symptoms of Menopause Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
  • 8.2 Vasomotor Symptoms of Menopause Treatment Key Players in China (2019-2020)
  • 8.3 China Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
  • 8.4 China Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
  • 9.2 Vasomotor Symptoms of Menopause Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
  • 10.2 Vasomotor Symptoms of Menopause Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
  • 11.2 Vasomotor Symptoms of Menopause Treatment Key Players in India (2019-2020)
  • 11.3 India Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
  • 11.4 India Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
  • 12.2 Vasomotor Symptoms of Menopause Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Amgen Inc.
    • 13.1.1 Amgen Inc. Company Details
    • 13.1.2 Amgen Inc. Business Overview
    • 13.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.1.4 Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020))
    • 13.1.5 Amgen Inc. Recent Development
  • 13.2 EndoCeutics, Inc.
    • 13.2.1 EndoCeutics, Inc. Company Details
    • 13.2.2 EndoCeutics, Inc. Business Overview
    • 13.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.2.4 EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.2.5 EndoCeutics, Inc. Recent Development
  • 13.3 Euroscreen S.A.
    • 13.3.1 Euroscreen S.A. Company Details
    • 13.3.2 Euroscreen S.A. Business Overview
    • 13.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.3.4 Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.3.5 Euroscreen S.A. Recent Development
  • 13.4 MenoGeniX, Inc.
    • 13.4.1 MenoGeniX, Inc. Company Details
    • 13.4.2 MenoGeniX, Inc. Business Overview
    • 13.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.4.4 MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.4.5 MenoGeniX, Inc. Recent Development
  • 13.5 Mithra Pharmaceuticals S.A.
    • 13.5.1 Mithra Pharmaceuticals S.A. Company Details
    • 13.5.2 Mithra Pharmaceuticals S.A. Business Overview
    • 13.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.5.4 Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.5.5 Mithra Pharmaceuticals S.A. Recent Development
  • 13.6 Pherin Pharmaceuticals, Inc.
    • 13.6.1 Pherin Pharmaceuticals, Inc. Company Details
    • 13.6.2 Pherin Pharmaceuticals, Inc. Business Overview
    • 13.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.6.4 Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.6.5 Pherin Pharmaceuticals, Inc. Recent Development
  • 13.7 Pivot Pharmaceuticals Inc
    • 13.7.1 Pivot Pharmaceuticals Inc Company Details
    • 13.7.2 Pivot Pharmaceuticals Inc Business Overview
    • 13.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.7.4 Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.7.5 Pivot Pharmaceuticals Inc Recent Development
  • 13.8 Radius Health, Inc.
    • 13.8.1 Radius Health, Inc. Company Details
    • 13.8.2 Radius Health, Inc. Business Overview
    • 13.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.8.4 Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.8.5 Radius Health, Inc. Recent Development
  • 13.9 TherapeuticsMD, Inc.
    • 13.9.1 TherapeuticsMD, Inc. Company Details
    • 13.9.2 TherapeuticsMD, Inc. Business Overview
    • 13.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
    • 13.9.4 TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
    • 13.9.5 TherapeuticsMD, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Vasomotor Symptoms of Menopause Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vasomotor Symptoms of Menopause Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Amgen Inc.
    EndoCeutics, Inc.
    Euroscreen S.A.
    MenoGeniX, Inc.
    Mithra Pharmaceuticals S.A.
    Pherin Pharmaceuticals, Inc.
    Pivot Pharmaceuticals Inc
    Radius Health, Inc.
    TherapeuticsMD, Inc.

    Market segment by Type, the product can be split into
    Estetrol
    Fezolinetant
    FP-101
    HBN-2
    Others
    Market segment by Application, split into
    Hospital
    Homecare
    Clinic

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now